Lumos Pharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
20.50
|
|
Average Rating
|
4.20
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.01
|
-0.86
|
0.15
|
14.85%
|
|
2022-06-30
|
-0.99
|
-0.94
|
0.05
|
5.05%
|
|
2022-03-31
|
-0.89
|
-0.92
|
-0.03
|
-3.37%
|
|
2021-12-31
|
-0.92
|
-0.67
|
0.25
|
27.17%
|
|
2021-09-30
|
-1.07
|
-0.90
|
0.17
|
15.89%
|
|
2021-06-30
|
-1.03
|
-1.04
|
-0.01
|
-0.97%
|
|
2021-03-31
|
-0.87
|
-1.04
|
-0.17
|
-19.54%
|
|
2020-12-31
|
-0.86
|
-0.31
|
0.55
|
63.95%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.72
|
|
2021-12-31
|
-3.65
|
|
2020-12-31
|
-0.89
|
|
2019-12-31
|
-10.35
|
|
2018-12-31
|
-12.96
|
|
2017-12-31
|
-2.35
|
|
2016-12-31
|
-2.94
|
|
2015-12-31
|
-1.44
|
|
2014-12-31
|
-6.59
|
|
2013-12-31
|
-11.16
|
|
2012-12-31
|
-10.08
|
|
2011-12-31
|
-5.63
|